Neuphoria Therapeutics Inc (NEUP) — Cash Flow-to-Debt Ratio
Neuphoria Therapeutics Inc (NEUP) has a Cash Flow-to-Debt Ratio of -0.93x as of December 2025, meaning its operating cash flow of $-6.44 Million could theoretically repay -1% of its total liabilities ($6.90 Million) in one year. See free cash flow generation of Neuphoria Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Neuphoria Therapeutics Inc Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Neuphoria Therapeutics Inc across 27 annual periods. Also explore NEUP shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Neuphoria Therapeutics Inc (1999–2025)
Year-by-year debt coverage analysis for Neuphoria Therapeutics Inc. For market capitalisation and broader financial context, see how much is Neuphoria Therapeutics Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 5.30x | $77.23 Million | $14.57 Million | ▲ +466.9% |
| 2024 | -1.45x | $-14.68 Million | $10.16 Million | ▲ +30.4% |
| 2023 | -2.08x | $-9.85 Million | $4.74 Million | ▲ +19.9% |
| 2022 | -2.59x | $-14.97 Million | $5.78 Million | ▼ -129.1% |
| 2021 | -1.13x | $-5.66 Million | $5.01 Million | ▼ -531.1% |
| 2020 | -0.18x | $-2.68 Million | $14.97 Million | ▲ +58.6% |
| 2019 | -0.43x | $-10.91 Million | $25.18 Million | ▼ -1.9% |
| 2018 | -0.43x | $-15.02 Million | $35.34 Million | ▼ -889.8% |
| 2017 | -0.04x | $-1.44 Million | $33.52 Million | ▲ +90.5% |
| 2016 | -0.45x | $-15.36 Million | $34.04 Million | ▼ -360.6% |
| 2015 | 0.17x | $4.94 Million | $28.51 Million | ▲ +125.6% |
| 2014 | -0.68x | $-12.91 Million | $19.06 Million | ▲ +24.9% |
| 2013 | -0.90x | $-10.05 Million | $11.14 Million | ▼ -19.7% |
| 2012 | -0.75x | $-4.01 Million | $5.32 Million | ▲ +49.7% |
| 2011 | -1.50x | $-8.98 Million | $6.00 Million | ▼ -8.4% |
| 2010 | -1.38x | $-7.10 Million | $5.14 Million | ▼ -34.8% |
| 2009 | -1.02x | $-4.99 Million | $4.87 Million | ▼ -0.6% |
| 2008 | -1.02x | $-6.61 Million | $6.49 Million | ▼ -11.4% |
| 2007 | -0.91x | $-6.30 Million | $6.89 Million | ▼ -58.7% |
| 2006 | -0.58x | $-3.75 Million | $6.51 Million | ▲ +16.0% |
| 2005 | -0.69x | $-3.33 Million | $4.86 Million | ▲ +3.0% |
| 2004 | -0.71x | $-2.98 Million | $4.22 Million | ▼ -11.1% |
| 2003 | -0.64x | $-2.51 Million | $3.95 Million | ▲ +28.0% |
| 2002 | -0.88x | $-2.91 Million | $3.29 Million | ▲ +88.9% |
| 2001 | -7.96x | $-2.61 Million | $327.78K | ▼ -38.4% |
| 2000 | -5.75x | $-843.87K | $146.83K | ▼ -2657.2% |
| 1999 | -0.21x | $-105.47K | $506.00K | — |